Opinion statement
Lumbosacral radiculoplexus neuropathy (LRPN) is a multifocal, asymmetric, painful neuropathic disorder affecting multiple levels of lumbosacral plexus, nerve roots, and distal nerves that emerge from the plexus. The disorder was first described in diabetic patients (DLRPN) and was later found to occur in nondiabetic patients as well. There have been debates as to the pathogenesis of DLRPN and LRPN. Recent detailed and extensive pathologic studies, however, have shown that the main pathogenesis is inflammation and microvasculitis affecting various components in the peripheral nerves, resulting in ischemic injury to the nerves. Even though studies on the natural history of this disorder have shown that the majority of patients recover within a few years after the attack without any treatment (although recovery is incomplete in many cases), it is a common practice, based on the pathophysiology and case series, to administer immunotherapy. Preliminary data from a controlled clinical trial failed to show significant improvement in outcomes measured by neurologic deficits (as judged by the Neuropathy Impairment Score) but did show improvement in symptoms (pain and positive sensory symptoms). Choices of immunotherapy include corticosteroids, intravenous immunoglobulin, plasma exchange, or a combination. Pain management, physical therapy, and treatment of depression remain mainstays for managing this disorder.
Similar content being viewed by others
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance, •• Of major importance
Garland H, Taverner D: Diabetic myelopathy. Br Med J 1953, 1(4825):1405–1408.
Garland H: Diabetic amyotrophy. Br Med J 1955, 2(4951):1287–1290.
Ellenberg M: Diabetic neuropathic cachexia. Diabetes 1974, 23:418–423.
Coppack SW, Watkins PJ: The natural history of diabetic femoral neuropathy. Q J Med 1991, 79(288):307–313.
O’Hare J, Abushisha F, Geoghegan M: Prevalence and forms of neuropathic morbidity in 800 diabetics. Irish J Med Sci 1994, 163:132–135.
Llewelyn J, Thomas PK, King RHM: Epineurial microvasculitis in proximal diabetic neuropathy. J Neurol 1998, 245:159–165.
Sander HW, Chokroverty S: Diabetic amyotrophy: current concepts. Semin Neurol 1996, 16(2):173–178.
Chokroverty S, Reyes MG, Rubino FA, Tonaki H: The syndrome of diabetic amyotrophy. Ann Neurol 1977, 2(3):181–194.
Said G, Goulon-Goeau C, Lacroix C, Moulonguet A: Nerve biopsy findings in different patterns of proximal diabetic neuropathy. Ann Neurol 1994, 35(5):559–569.
Dyck PJB, Norell JE, Dyck PJ: Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology 1999, 53(9):2113–2121.
Dyck PJB, Engelstad J, Norell J, Dyck PJ: Microvasculitis in non-diabetic lumbosacral radiculoplexus neuropathy (LSRPN): similarity to the diabetic variety (DLSRPN). J Neuropathol Exp Neurol 2000, 59(6):525–538.
Kelkar P, Moeen M, Gareth P: Distinctive pathologic findings in proximal diabetic neuropathy. Neurology 2000, 55:83–88.
Dyck PJB, Windebank A: Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment. Muscle Nerve 2002, 25:477–491.
Kawamura N, Dyck PJB, Schmeichel A, et al.: Inflammatory mediators in diabetic and non-diabetic lumbosacral radiculoplexus neuropathy. Acta Neuropathol 2008, 115:231–239.
Dyck PJB, O’Brien P, Bosch P, et al.: The multi-center double-blind controlled trial of IV methylprednisolone in diabetic lumbosacral radiculoplexus neuropathy [abstract]. Neurology 2006, 66(suppl 2):A191.
Krendel DA, Costigan DA, Hopkins LC: Successful treatment of neuropathies in patients with diabetes mellitus. Arch Neurol 1995, 52(11):1053–1061.
Pascoe MK, Low PA, Windebank AJ, et al: Subacute diabetic proximal neuropathy. Mayo Clin Proc 1997, 72:1123–1132.
Kilfoyle D, Kelkar P, Parry G: Pulsed methylprednisolone is a safe and effective treatment for diabetic amyotrophy. J Clin Neuromuscular Dis 2003, 4:168–170.
Dyck PJB, Norell J, Dyck P: Methylprednisolone may improve lumbosacral radiculoplexus neuropathy. Can J Neurol Sci 2001, 28:224–227.
•• Chan YC, Lo YL, Chan E: Immunotherapy for diabetic amyotrophy. Cochrane Database Syst Rev 2009, (3):CD006521. A recent, in-depth review on therapeutic options in these disorders.
Disclosure
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thaisetthawatkul, P., Dyck, P.J.B. Treatment of Diabetic and Nondiabetic Lumbosacral Radiculoplexus Neuropathy. Curr Treat Options Neurol 12, 95–99 (2010). https://doi.org/10.1007/s11940-010-0059-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11940-010-0059-8